Dr Stephen Morris, Consultant Clinical Oncologist

Dr Stephen Morris

Consultant Clinical Oncologist

Book online
|

Dr Stephen Morris MBBS, MRCP, FRCR

Consultant Clinical Oncologist

MBBS, MRCP, FRCR

Dr Stephen Morris

Consultant Clinical Oncologist MBBS, MRCP, FRCR

Book online
|
MBBS, MRCP, FRCR

Areas of expertise

  • Prostate cancer
  • Radiotherapy
  • Chemotherapy
  • Brachytherapy
  • Skin cancer

Recommendations for Dr Morris

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • by Dr Justine Kluk, Dermatologist

    Recommended oncologist

  • by Dr Justine Kluk, Dermatologist

    Recommended oncologist

  • Address

    • London Bridge Hospital

      27 Tooley Street, London, SE1 2PR

    • London Radiotherapy Centre

      Borough Wing, Lower Ground Floor, Guy's Hospital, Great Maze Pond, London, SE1 9RT

    • Private Care at Guy's at London Bridge Hospital

      Great Maze Pond, London, SE1 9RT

    About Dr Stephen Morris

    GMC number: 4200000

    Year qualified: 1995

    Place of primary qualification: University of London

    Areas of expertise

    • Prostate cancer
    • Skin cancers
    • Cutaneous lymphoma
    • Urological cancers
    • Dermatological oncology
    • Melanoma
    • Radiotherapy
    • Chemotherapy
    • Urological oncology
    • Skin cancers
    • Clinical oncology
    • Prostate brachytherapy

    Professional memberships

    Royal College of Radiologists
    General Medical Council

    Articles by Dr Stephen Morris

    Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: effect of specific prognostic markers on survival and development of a prognostic model

    Mogamulizumab versus vorinostat in previously treated cutaneous t-cell lymphoma (mavoric): an international, open-label, randomised, controlled phase 3 trial

    Evaluation of a belly board immobilisation device for rectal cancer patients receiving pre-operative chemoradiation